Patent · US Expired

Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

US6267986A · kind A · utility

9Cited by
14References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 1999
Grant dateJul 31, 2001
Priority date
Expiry dateSep 24, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/495
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a process for the preparation of a controlled release pharmaceutical composition comprising two discrete zones wherein the first discrete zone comprises therapeutically effective amount of pseudoephedrine or its pharmaceutically acceptable salt as active ingredient and the second discrete zone comprises a therapeutically effective amount of a long-acting antihistamine selected from the group consisting of loratadine, azatidine, fexofenadine, terfenadine, cetirizine, astemizole, and levocabastine, or their pharmaceutically acceptable salt as active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.